Quality Matters is the only full-service agency dedicated to creating quality-driven strategies and innovative communications that inspire member acquisition and optimize patient/HCP engagement to achieve better cost, care, and outcomes. Quality Matters creates value campaigns for its clients by integrating its understanding of quality measures/scores, population health management, and creative excellence on both a national and regional level. Our core services include member acquisition and retention campaigns, stakeholder education and engagement programs, branding, quality improvement, population health management, medication adherence, and care transitions.
Our mission is to improve quality in the accountable healthcare environment. Our aim is to support better patient/caregiver experiences and satisfaction, care coordination and safety, preventive health, and at-risk patient care, resulting in achievement of population health goals and lower costs to organizations.
Quality Matters leverages the current focus on quality to make it actionable for our clients in the healthcare marketplace: accountable care organizations, pharmaceutical manufacturers, provider groups, patients, employers, or policy groups. We are working to define the transformation to value-based care.
In addition to randomized clinical trials and proof of efficacy and safety, healthcare reform is demanding evidence of value to determine coverage and reimbursement policy. Real world evidence incorporates quality measures, performance metrics, comparative effectiveness, and a variety of institutional, professional and patient outcome studies to assess a products performance in a “real world” setting. These studies are growing in magnitude and importance as healthcare reform strives to define value.
Prior to establishing his consulting practice on Healthcare Reform and Market Access, John was Senior Vice President, Evidence to Access (E2A) at the MedErgy Health Group, a Cello Health Company where he established and Branded the E2A offering and led global initiatives addressing strategy and market access for diabetes, CNS and cardiovascular disease. John also served as Vice President, Strategic Planning and Managed Markets at Cardinal Health, where he was appointed as advisor to Cardinal’s Executive Committee on the strategic implication of new healthcare legislation and led multidivisional projects linking physician, supply chain, pharmacy, drug development, and reimbursement initiatives. While at Cardinal, he also served as the in-house strategic planning consultant to Centocor on the global pre-launch planning for Simponi. Prior to Cardinal, John was Vice President of Marketing and a Principal at Breathnet, Inc., a start-up network of almost 100 pulmonologists in the tri-state area that segmented the respiratory care market with a provider specific quality care alternative. He has also had successful tenures with Merck-Medco Managed Care and Wyeth-Ayerst designing disease management programs and IPG as Head of the ICCLowe Managed Markets Group.
John’s Brand management experience includes Project Leadership for the Glaxo/Warner-Lambert Joint Venture, where was responsible for the Rx-to-OTC switch of Zantac. His advertising experience includes professional and consumer marketing as Senior Vice President at S&H, the healthcare division of Young & Rubicam, where he directed marketing for the Rx-to-OTC Switch of Benadryl and Revlon.
He has been extensively involved in following Healthcare Reform and has presented at National Industry Conferences on the implications of new legislation for the healthcare industry.
John received his MBA from the Whittemore School of Business and Economics at the University of New Hampshire and his BA in Psychology and Economics from Connecticut College, New London, CT.
Van has been working in the healthcare communications industry for over 10 years. As a Medical Director, she has been responsible for strategic messaging and promotional content development for pharmaceutical products for Alzheimer’s disease, hypertension, depression, stroke, pain, and allergy/asthma, among others. Additionally, much of her career has been in managed markets, working with clients to secure and maintain product access through development of unique value propositions, effective communication of health economic data, and strategic execution of value-add offerings.
More recently, Van was with a midsized pharmaceutical company, responsible for developing and delivering effective payer marketing resources in challenging and generic-laden marketplaces. As provisions of the Affordable Care Act began to take root, she became singularly engaged in understanding the new healthcare environment, identifying gaps and opportunities, and formulating strategies and resources to address new customers and challenges. With a strong desire to aid in the improvement of healthcare quality in this new era of value-based healthcare, she joined forces with Olivia Banyon at Quality Matters to provide customers with effective and actionable ways to enhance patient outcomes.
Van holds a PhD in Pharmacology and Toxicology from Virginia Commonwealth University, School of Medicine.